What is the official website of Phileo by Lesaffre | Pet Care ?

The official website of Phileo by Lesaffre | Pet Care is https://phileo-lesaffre.com/en/pets/.

What is Phileo by Lesaffre | Pet Care's cybersecurity risk score?

Phileo by Lesaffre | Pet Care has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Phileo by Lesaffre | Pet Care experienced?

According to Rankiteo, Phileo by Lesaffre | Pet Care currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Phileo by Lesaffre | Pet Care been affected by any supply chain cyber incidents ?

According to Rankiteo, Phileo by Lesaffre | Pet Care has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Phileo by Lesaffre | Pet Care have SOC 2 Type 1 certification ?

According to Rankiteo, Phileo by Lesaffre | Pet Care is not certified under SOC 2 Type 1.

Does Phileo by Lesaffre | Pet Care have SOC 2 Type 2 certification ?

According to Rankiteo, Phileo by Lesaffre | Pet Care does not hold a SOC 2 Type 2 certification.

Does Phileo by Lesaffre | Pet Care comply with GDPR ?

According to Rankiteo, Phileo by Lesaffre | Pet Care is not listed as GDPR compliant.

Does Phileo by Lesaffre | Pet Care have PCI DSS certification ?

According to Rankiteo, Phileo by Lesaffre | Pet Care does not currently maintain PCI DSS compliance.

Does Phileo by Lesaffre | Pet Care comply with HIPAA ?

According to Rankiteo, Phileo by Lesaffre | Pet Care is not compliant with HIPAA regulations.

Does Phileo by Lesaffre | Pet Care have ISO 27001 certification ?

According to Rankiteo,Phileo by Lesaffre | Pet Care is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Phileo by Lesaffre | Pet Care operate in ?

Phileo by Lesaffre | Pet Care operates primarily in the Biotechnology Research industry.

How many employees does Phileo by Lesaffre | Pet Care have ?

Phileo by Lesaffre | Pet Care employs approximately None employees people worldwide.

Does Phileo by Lesaffre | Pet Care own any subsidiaries ?

Phileo by Lesaffre | Pet Care presently has no subsidiaries across any sectors.

How many LinkedIn followers does Phileo by Lesaffre | Pet Care have ?

Phileo by Lesaffre | Pet Care's official LinkedIn profile has approximately 841 followers.

What is the NAICS classification code for Phileo by Lesaffre | Pet Care ?

Phileo by Lesaffre | Pet Care is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Phileo by Lesaffre | Pet Care have a Crunchbase profile ?

No, Phileo by Lesaffre | Pet Care does not have a profile on Crunchbase.

Does Phileo by Lesaffre | Pet Care have a LinkedIn profile ?

Yes, Phileo by Lesaffre | Pet Care maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/phileo-petcare.

How many cybersecurity incidents has Phileo by Lesaffre | Pet Care experienced ?

As of August 25, 2026, Rankiteo reports that Phileo by Lesaffre | Pet Care has not experienced any cybersecurity incidents.

How many peer or competitor companies does Phileo by Lesaffre | Pet Care have ?

Phileo by Lesaffre | Pet Care has an estimated 4,750 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

PLPC

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

Phileo by Lesaffre | Pet Care Vendor Cyber Rating & Cyber Score

phileo-lesaffre.com

Add Your Compliance Badge

The Phileo dedicated Pet Team uses the expertise of the Lesaffre Group in fermentation biotechnologies to better nourish and protect dogs and cats, at all life stages, by providing a complete program of innovative solutions for pet food and pet supplement industries. These solutions encompass digestive care, immunity reinforcement, stress protection and sustainable nutrition.

PLPC A.I CyberSecurity Scoring

Scoring History

PLPC

Phileo by Lesaffre | Pet Care CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

PLPC Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for PLPC

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Phileo by Lesaffre | Pet Care in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Phileo by Lesaffre | Pet Care in 2026.

Incident Types PLPC vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Phileo by Lesaffre | Pet Care in 2026.

Incident History - PLPC (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Phileo by Lesaffre | Pet Care Subsidiaries

PLPC

Biotechnology Research

Website: https://phileo-lesaffre.com/en/pets/

Company Size: 51-200 employees

LesaffreFood and Beverage Manufacturing

Biospringer by LesaffreFood and Beverage Manufacturing

Gnosis by LesaffreBiotechnology Research

Agrauxine by LesaffreFarming

Lesaffre UK & IrelandFood and Beverage Services

Baking with LesaffreFood Production

Ennolys by LesaffreFood and Beverage Manufacturing

Ennatech - CDMO Fermentation industrielle & BiotechnologiesResearch Services

Procelys by LesaffreBiotechnology

Lesaffre ArgentinaFood and Beverage Manufacturing

Yeast Industries Companies L.T.D (ASTRICO)Food and Beverage Manufacturing

LIS by LesaffreFood and Beverage Manufacturing

Lesaffre North AmericaFood and Beverage Manufacturing

Lesaffre IbéricaFood Production

Lesaffre TürkiyeFood Production

Phileo by LesaffreBiotechnology

Phileo by Lesaffre FRANCEBiotechnology Research

Phileo by Lesaffre NORTH AMERICABiotechnology Research

The Pig Microbiome PodcastFood and Beverage Manufacturing

Loading…

Phileo by Lesaffre | Pet Care Similar Companies

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Loading…

NEWS

Phileo by Lesaffre | Pet Care CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53532

SUMMARY

OpenEXR is the reference implementation and specification for the EXR image format, widely used in the motion picture industry. In versions 3.4.0 through 3.4.12, a crafted HTJ2K-compressed EXR file causes an unconditional process abort in any application that calls exr_start_read() on untrusted input, resulting in denial of service. The crash is triggered by a QCD marker whose lower five bits are zero, which OpenEXR passes into the vendored OpenJPH library while constructing the codestream and evaluating its quantization delta parameters. OpenJPH uses an assertion rather than a recoverable error to validate those bits, so any invalid value calls abort() directly and cannot be intercepted by surrounding error handling, a problem compounded by OpenEXR wrapping only its internal HT header parser in error handling while leaving the later codestream read and construction calls unprotected. This issue has been resolved in version 3.4.13.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: )

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-78435

SUMMARY

A vulnerability has been found in Faveo Helpdesk up to 2.0.3. Affected is the function unlink of the file app/Http/Controllers/Admin/helpdesk/SettingsController.php of the component Logo Handler. Such manipulation of the argument data1 leads to path traversal. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 3.8)

cvss2

Base Score: 4.7

Complexity: LOW

AV:N/AC:L/Au:M/C:N/I:P/A:P

cvss3

Base Score: 3.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

1.2

REFERENCES

CVE-2026-78434

SUMMARY

A flaw has been found in Faveo Helpdesk up to 2.0.3. This impacts the function FormController::post_ticket_reply of the file app/Http/Controllers/Client/helpdesk/FormController.php of the component post-ticket-reply Endpoint. This manipulation causes missing authentication. The attack can be initiated remotely. The exploit has been published and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 6.5)

cvss2

Base Score: 6.4

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:P

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-78284

SUMMARY

Unauthenticated Arbitrary File Deletion in MasterStudy LMS <= 3.7.42 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 8.6)

cvss3

Base Score: 8.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H

Impact Score

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/masterstudy-lms-learning-management-system/vulnerability/wordpress-masterstudy-lms-plugin-3-7-42-arbitrary-file-deletion-vulnerability?_s_id=cve

CVE-2026-78282

SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Stripe Payments <= 2.1.2 versions.

Published

Date2026-08-24

Updated

Date2026-08-24

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/stripe-payments/vulnerability/wordpress-stripe-payments-plugin-2-1-2-cross-site-scripting-xss-vulnerability?_s_id=cve

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…